Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML- specific primary cytotoxic T-cell response

Genes Chromosomes and Cancer

Volumn 20, Issue 3, 1997, Pages 215-223

  Eibl, Brigitte ^a   Ebner, Susanne ^b   Duba, Christoph ^a   Böck, Günther ^a   Romani, Nikolaus ^b   Erdel, Martin ^a   Gächter, Anne ^a   Niederwieser, Dietger ^a   Schuler, Gerold ^b,c  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD83 ANTIGEN; CD86 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYUREA; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHYTOHEMAGGLUTININ; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ARTICLE; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; LYMPHOBLAST; LYMPHOBLASTOID CELL LINE; MONONUCLEAR CELL; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

CELL LINE, TRANSFORMED; CELLS, CULTURED; CLONE CELLS; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, CHRONIC; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; PHILADELPHIA CHROMOSOME; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030729988     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199711)20:3<215::AID-GCC1>3.0.CO;2-5     Document Type: Article

References (49)

1. Bakhshi A, Minowada J, Arnold A, Cossman J, Jensen JP, Whang-Peng J, Waldmann TA, Korsmeyer SJ (1983) Lymphoid blast crises of chronic myelogenous leukemia represent stages in the development of B-cell precursors. New Engl J Med 309:826-833.
2. Barrett A, Jiang YZ (1992) Immune responses to chronic myeloid leukaemia. Bone Marrow Transplant 9:305-311.
3. Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N (1996) Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 196:121-135.
4. + T cells. J Clin Invest 94:797-807.
5. Bocchia M, Korontsvit T, Xu Q, Mackinnon S, Young Yang S, Sette A, Scheinberg DA (1996) Specific human cellular immunity to bcr-abl oncogene-derived peptides. Blood 87:3587-3592.
6. + helper cell requirement in cytotoxic T lymphocyte responses. Eur J Immunol 18:219-223.
7. Butturini A, Bortin MM, Gale RP (1987) Graft-vs-leukemia following bone marrow transplantation. Bone Marrow Transplant 2:233-242.
8. Cella M, Sallusto F, Lanzavecchia A (1997) Origin, maturation and antigen presenting function of dendritic cells. Current Opinion in Immunology 9:10-16.
9. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD Jr (1996) Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J Exp Med 183:283-287.
10. Champlin RE, Golde DW (1985) Chronic myelogenous leukemia: Recent advances. Blood 65:1039-1047.
11. BCR-ABL protein. Proc Natl Acad Sci USA 89:1468-1472.
12. Cohen PJ, Cohen PA, Rosenberg SA, Katz SI, Mulé JJ (1994) Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells. Eur J Immunol 24:315-319.
13. De Bruijn MLH, Nieland JD, Schumacher TNM, Ploegh HL, Kast WM, Melief CJM (1992) Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses. Eur J Immunol 22:3013-3020.
14. De Klein A, van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR (1982) A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 300:765-767.
15. Fialkow PJ and Singer JW (1989) Chronic leukemias. In DeVita VT, Hellman E, Rosenberg SA (eds): Cancer. Principles & Practice of Oncology. Grand Rapids, New York: J.B. Lippincott, pp 1836-1852.
16. Flamand V, Sornasse T, Thielemans K, Demanet C, Bakkus M, Bazin H, Tielemans F, Leo O, Urbain J, Moser M (1994) Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vitro. Eur J Immunol 24:605-610.
17. Grabbe S, Beissert S, Schwarz T, Granstein RD (1995) Dendritic cells as initiators of tumor immune responses: A possible strategy for tumor immunotherapy? Immunol Today 16:117-121.
18. Griffin JD, Tantravahi R, Canellos GP, Wisch JS, Reinherz EL, Sherwood G, Beveridge RP, Daley JF, Lane H, Schlossman SF (1983) T-cell surface antigens in a patient with blast crisis of chronic myeloid leukemia. Blood 61:640-644.
19. Heisterkamp N, Stephenson JR, Groffen J, Hansen PF, De Klein A, Bartram CR, Grosveld G (1983) Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature 306:239-242.
20. Heisterkamp N, Stam K, Groffen J, De Klein A, Grosveld G (1985) Structural organization of the bcr gene and its role in the Ph′ translocation. Nature 315:758-761.
21. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey H, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM (1990) Graft versus-leukemia reactions after bonemarrow transplantation. Blood 75:555-562.
22. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, Engleman EG, Levy R (1996) Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med 2:52-58.
23. Inaba K, Steinman RM (1985) Protein-specific helper T-lymphocyte formation initiated by dendritic cells. Science 229:475-479.
24. + cytotoxic T lymphocytes by dendritic cells. J Exp Med 166:182-194.
25. Kearney L, Orchard KH, Hibbin J, Goldman JM (1982) T-cell cytogenetics in chronic granulocytic leukaemia. Lancet 1:858.
26. Kolb HJ, Mittermüller J, Clemm Ch, Holler E, Ledderose G, Brehm G, Heim M, Wilmanns W (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76:2462-2465.
27. Konopka JB, Watanabe SM, Witte ON (1984) An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 37:1035-1042.
28. Konopka JB, Clark S, McLaughlin J, Nitta M, Kato Y, Strife A, Clarkson B, Witte ON (1986) Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients. Proc Natl Acad Sci USA 83:4049-4052.
29. Macatonia SE, Taylor PM, Knight SC, Askonas BA (1989) Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J Exp Med 169:1255-1264.
30. Martin PJ, Najfeld V, Hansen JA, Penfold GK, Jacobson RJ, Fialkow PJ (1980) Involvement of the B-lymphoid system in chronic myelogenous leukaemia. Nature 287:49-50.
31. Mayordomo JI, Zorma T, Storkus WJ, Zitvogel L, Celluzi C, Falo LD, Melief CJM, Ildstad ST, Kast WM, Deleo AB, Lotze MT (1995) Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic anti-tumour immunity. Nature Med 1:1297-1302.
32. Mes-Masson A-M, Witte ON (1987) Role of the abl oncogene in chronic myelogenous leukemia. Adv Cancer Res 49:53-74.
33. Mukherji B, Chakraborty NG, Yamasaki S, Okino T, Yamase H, Sporn JR, Kurtzman SK, Egrin MF, Ozols J, Meehan J, Mauri F (1995) Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. Proc Natl Acad Sci USA 92:8078-8082.
34. Niederwieser D, Grassegger A, Auböck J, Herold M, Nachbaur D, Rosenmayr A, Gåchter A, Nussbaumer W, Gaggl S, Ritter M, Huber Ch (1993) Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens. Blood 81:2200-2208.
35. Nitta M, Kato Y, Strife A, Wachter M, Fried J, Perez A, Jhanwar S, Duigou-Osterndorf R, Chaganti RSK, Clarkson B (1985) Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia. Blood 66:1053-1061.
36. 1-positive T lymphoblastic transformation of chronic granulocytic leukaemia in a lymph node. Lancet 2:1053.
37. Romani N, Gruner S, Brang D, Kämpgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G (1994) Proliferating dendritic cell progenitors in human blood. J Exp Med 180:83-93.
38. Romani N, Reider D, Heuer M, Ebner S, Eibl B, Niederwieser D, Schuler G (1996) Generation of mature dendritic cells from human blood: An improved method with special regard to clinical applicability. J Immunol Methods 196:137-151.
39. Shabtai F, Gafter U, Weiss S, Djaldetti M, Halbrecht I (1980) New complex Ph′ translocation t(10;14;22) in bone marrow cells and in PHA-stimulated peripheral blood cultures in chronic myelocytic leukaemia. J Cancer Res Clin Oncol 96:287-294.
40. Shtivelman E, Lifshitz B, Gale RP, Canaani E (1985) Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315:550-554.
41. Smyth LA, Witt CS, Christiansen FT, Herrmann RP, Hollingsworth PN, Townend DC, Edward E, Dawkins RL (1993) The MHC influences acute graft versus host disease in MHC matched adults undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 12:351-355.
42. Stam K, Heisterkamp N, Grosveld G, De Klein A, Verma RS, Coleman M, Dosik H, Groffen J (1985) Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome. New Engl J Med 313:1429-1433.
43. Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 9:271-296.
44. Talpaz M, Kantarjian HM, McCredie KB, Trujillo JM, Keating MJ, Gutterman JU (1986) Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha a in chronic myelogenous leukemia. New Engl J Med 314:1065-1069.
45. BCR-ABL protein by human T cells. Leukemia 9;1344-1348.
46. + helper T cells. J Exp Med 171:1315-1318.
47. Zhou LJ, Tedder TF (1995) Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol 154:3821-3835.
48. Zhou LJ, Schwarting R, Smith HM, Tedder TF (1992) A novel cell-surface molecule expressed by human interdigitating reticulum cells. Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol 149:735-742.
49. Zier K, Huber Ch, Braunsteiner H (1977) Linear density gradient separation of human lymphocyte subsets. I. Analysis by mixed leukocyte culture and cell mediated lympholysis responses. Eur J Immunol 7:366.